Femogesal 21 Tablets

Femogesal 21 Tablets

Description:

Femogesal 21 tablets are a prescription combined oral contraceptive medicine containing ethinyl estradiol and gestodene. It is designed for reliable hormonal birth control in women of reproductive age. As a low-dose estrogen-progestin pill, Femogesal helps prevent unwanted pregnancy by regulating the menstrual cycle, inhibiting ovulation, and creating multiple barriers to fertilization and implantation. Manufactured by Technopharma, this product provides 21 film-coated tablets per pack for cyclical use under medical supervision.

Indications:

• Hormonal contraception for women of reproductive age wishing to prevent pregnancy.
• Regulation of the menstrual cycle in women prescribed a combined oral contraceptive by their doctor.
• May help reduce menstrual pain (dysmenorrhea) and menstrual blood loss in women suitable for combined oral contraceptives, as assessed by a physician.
• May improve cycle predictability and reduce ovulation-related symptoms when used as directed.

Active Ingredients / Key Components:

• Ethinyl estradiol – 0.03 mg per film-coated tablet (synthetic estrogen).
• Gestodene – 0.075 mg per film-coated tablet (synthetic progestin).
• Excipients: film-coating and tablet core ingredients (such as fillers, binders, colorants, and stabilizers) – exact composition not available in the provided information.

Dosage & Administration / How to Use:

• Femogesal is for oral use only and must be taken exactly as prescribed by your doctor.
• Standard regimen: 1 tablet once daily for 21 consecutive days, preferably at the same time each day, followed by a 7-day tablet-free interval (during which a withdrawal bleed usually occurs).
• Start of first pack (for women not using hormonal contraception in the previous cycle): take the first tablet on day 1 of the menstrual cycle (first day of bleeding), or as otherwise directed by your doctor.
• Swallow the tablet whole with water, with or without food. Do not chew or crush.
• After the 7-day break, start the next pack on the same weekday, even if bleeding has not completely stopped.
• Missed dose: if a tablet is missed by less than 12 hours, take it as soon as remembered and continue the remaining tablets at the usual time. If more than 12 hours have passed, contraceptive protection may be reduced; follow the missed-pill instructions provided in the patient leaflet and use additional non-hormonal contraception (e.g., condoms) as advised.
• Vomiting or severe diarrhea within 3–4 hours of taking a tablet may reduce absorption; follow missed-pill guidance and consult your doctor or pharmacist.
• Do not exceed the prescribed daily dose. Do not use continuously without medical follow-up.

Clinical Benefits:

• Provides highly effective hormonal contraception when taken correctly, significantly reducing the risk of unintended pregnancy.
• Prevents ovulation and thickens cervical mucus, making it more difficult for sperm to reach an egg.
• Alters the endometrial lining, reducing the likelihood of implantation if fertilization occurs.
• Helps regulate menstrual cycles, often resulting in more predictable and lighter periods.
• May reduce menstrual cramps and menstrual-related discomfort in suitable users.
• May improve cycle-related symptoms such as ovulation pain in some women, as assessed by a healthcare professional.

Warnings & Contraindications:

• Femogesal is a prescription-only hormonal contraceptive and should be used under the supervision of a qualified healthcare professional.
• Do not use if you are pregnant or suspect you may be pregnant.
• Contraindicated in women with a history of venous or arterial thromboembolism (e.g., deep vein thrombosis, pulmonary embolism, stroke, heart attack) or known thrombophilia.
• Contraindicated in women with severe or multiple risk factors for blood clots (e.g., major surgery with prolonged immobilization, certain cardiovascular conditions) as determined by a doctor.
• Do not use in cases of known or suspected hormone-dependent malignancies (such as certain breast or endometrial cancers) or unexplained vaginal bleeding.
• Contraindicated in severe liver disease, active liver tumors, or history of liver tumors, until liver function has returned to normal.
• Use with caution and only under medical advice if you have conditions such as hypertension, diabetes, migraine (especially with aura), obesity, high cholesterol or triglycerides, or a strong family history of thromboembolic disease.
• Smoking, especially in women over 35 years, increases the risk of serious cardiovascular side effects; smokers should be strongly advised to quit or consider non-hormonal contraception.
• Certain medicines (e.g., some antiepileptics, rifampicin, rifabutin, some antiretrovirals, herbal products like St. John’s wort) may reduce the effectiveness of Femogesal; inform your doctor about all medications and supplements you are taking.
• This product does not protect against HIV (AIDS) or other sexually transmitted infections (STIs); use condoms for STI protection.
• Consult your doctor before use if you are breastfeeding, have liver disease, kidney disease, diabetes, migraine, depression, gallbladder disease, or any chronic medical condition.
• Not intended to diagnose, treat, cure, or prevent any disease beyond its approved indication for contraception.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, abdominal discomfort, breast tenderness, headache, mood changes, and spotting or breakthrough bleeding, especially during the first few cycles.
• Some users may experience changes in body weight, changes in libido, fluid retention, or mild skin changes.
• Serious but less common side effects include signs of blood clots (such as sudden shortness of breath, chest pain, severe headache, vision changes, leg swelling or pain), severe abdominal pain, jaundice (yellowing of skin or eyes), or severe depression.
• Stop taking the tablets and seek immediate medical attention if you experience symptoms suggestive of a blood clot, stroke, heart attack, or severe allergic reaction (such as swelling of face, lips, tongue, or difficulty breathing).
• If any side effects are persistent, bothersome, or unexpected, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: combined oral contraceptive medicine.
• Form: film-coated tablet.
• Strength per tablet: ethinyl estradiol 0.03 mg + gestodene 0.075 mg.
• Pack size: 21 tablets per pack (21-day regimen followed by 7-day tablet-free interval).
• Route of administration: oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.